hVIVO Plc. HVO
Dividend Summary
The previous hVIVO Plc. dividend was 0.2p and it went ex 1 year ago and it was paid 12 months ago.
There is typically 1 dividend per year (excluding specials).
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | Paid | – |
| Type | Final | – |
| Per share | 0.2p | – |
| Declaration date | 10 Apr 2025 (Thu) | – |
| Ex-div date | 15 May 2025 (Thu) | – |
| Pay date | 11 Jun 2025 (Wed) | – |
Enter the number of hVIVO Plc. shares you hold and we'll calculate your dividend payments:
Sign up for hVIVO Plc. and we'll email you the dividend information when they declare.
Add hVIVO Plc. to receive free notifications when they declare their dividends.
Your account is set up to receive hVIVO Plc. notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| Paid | Final | 10 Apr 2025 | 15 May 2025 | 11 Jun 2025 | GBP | 0.2p | 0.2p | 😄 |
| Paid | Final | 09 Apr 2024 | 18 Apr 2024 | 20 May 2024 | GBP | — | 0.2p | |
| Paid | Special | 25 Apr 2023 | 04 May 2023 | 09 Jun 2023 | GBP | — | 0.45p |
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0p | — |
| 2007 | 0.0p | 0% |
| 2008 | 0.0p | 0% |
| 2009 | 0.0p | 0% |
| 2010 | 0.0p | 0% |
| 2011 | 0.0p | 0% |
| 2012 | 0.0p | 0% |
| 2013 | 0.0p | 0% |
| 2014 | 0.0p | 0% |
| 2015 | 0.0p | 0% |
| 2016 | 0.0p | 0% |
| 2017 | 0.0p | 0% |
| 2018 | 0.0p | 0% |
| 2019 | 0.0p | 0% |
| 2020 | 0.0p | 0% |
| 2021 | 0.0p | 0% |
| 2022 | 0.0p | 0% |
| 2023 | 0.2p | 100% |
| 2024 | 0.2p | 0% |
hVIVO Plc. Optimized Dividend Chart
- Dividend Yield Today
- 0.0%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 5.3% on 09 December 2025
- 52 Week Low
- 0.0% on 13 May 2026
- Next Ex-Div-Date Countdown
- Sign Up Required
About hVIVO Plc.
Open Orphan plc, formerly Venn Life Sciences Holdings plc, is engaged in the pharma services business. The Company is also engaged in building an orphan drug consulting services platform that helps pharma companies commercialize their products in Europe. The Company consists of four elements: a European clinical research organization and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians, and a Health Data Platform. The Company provides fragmented orphan drug services. The Company acquires and consolidates series of orphan drug services companies. It also provides digital data platforms to support companies in research & development and commercialization.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- United Kingdom
- Share Price
- £0.08 (yesterday's closing price)
- Shares in Issue
- 688 million
- Market Cap
- £56mn
- 0
- Market Indices
- none
